Log In
Print
BCIQ
Print
Print this Print this
 

Edurant, rilpivirine (TMC278)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionDiarylpyrimidine non-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target DNA polymerase
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection in treatment-naïve patients; Treat HIV-1 infection
Regulatory Designation Japan - Orphan Drug (Treat HIV-1 infection)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$99.6M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today